Cancer incidence and mortality in China, 2015

Zhang, Siwei; Sun, Kexin; Zheng, Rongshou; Zeng, Hongmei; Wang, Shaoming; Chen, Ru; Wei, Wenqiang; He, Jie

doi:10.1016/j.jncc.2020.12.001

Cited by 305 publications

(282 citation statements)

References 24 publications

Supporting

Mentioning

251

Contrasting

Order By: Relevance

“…As Table 1 displays, the average Baidu Search Index of leukemia was the highest among cancers (M=4,734.769), and conversely, the lowest was head and neck cancer (M=31.224). According to the latest data, leukemia was not even the top 10 most common cancers in terms of crude incidence rates and mortality rates [29,30], but the one most concerned by Chinese netizens.…”

Section: Resultsmentioning

confidence: 99%

“…What sets media attention apart is its much stronger variation, where the CV of the Baidu Media Index of ten years and inter years mostly exceeds 1. Though the disparity in coverage may be practically reasonable, inasmuch as the time, resources, and manpower of news organizations are limited, such practice may take negative effects on health behavior and decision-making considering the fact that estimated millions of people suffer from these types of cancers, like oesophageal and thyroid cancer, the incidence rates of which respectively ranked sixth and eighth in China [29,30].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Diverging from News Media: An Exploratory Study on the Changing Dynamics between Media and Public Attention on Cancer in China from 2011-2020

Huang¹,

Xu²,

Su³

2021

Preprint

View full text Add to dashboard Cite

Over the past decade, China has witnessed fast-paced technological advancements in the media industry, as well as major shifts in the health agenda portrayed in the media. Therefore, a key starting point when discussing health communication lies in whether media attention and public attention towards health issues are structurally aligned, and to what extent the news media guide public attention. Based on data mined from 73,060 sets of the Baidu Search Index and Media Index on 20 terms covering different types of cancer from 2011 to 2020, the Granger test demonstrates that, in the last decade, public attention and media attention towards cancer in China has gone through two distinct phases. During the first phase, 2011-2015, Chinese news media still held the key in transferring the salience of issues on most cancer types to the public. In the second phase, from 2016-2020, public attention towards cancer has gradually diverged from media coverage, mirroring the imbalance and mismatch between the demand of active public and the supply of cancer information from news media. This study provides an overview of the dynamic transition on cancer issues in China over a ten-year span, along with descriptive results on public and media attention towards specific cancer types.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Diverging from News Media: An Exploratory Study on the Changing Dynamics between Media and Public Attention on Cancer in China from 2011-2020

Huang¹,

Xu²,

Su³

2021

Preprint

View full text Add to dashboard Cite

show abstract

“…GLOBOCAN estimated in 2018 that the occurrence and death of esophageal cancer in China accounted for 53.7% and 55.7% of the world's esophageal cancer cases, respectively [2] . Although the actual number of cases and deaths of esophageal cancer is lower than GLOBOCAN's estimate [1] , its poor prognosis is still an important cancer burden. Therefore, the discovery of new biomarkers for esophageal cancer is of great significance to provide evidence for the diagnosis and treatment of esophageal cancer.…”

Section: Introductionmentioning

confidence: 88%

“…Cancer has become the leading cause of death in China. Based on the latest data from the National Cancer Center, the incidence of esophageal cancer ranks the sixth among all malignant tumors and the fourth among digestive system tumors [1] . GLOBOCAN estimated in 2018 that the occurrence and death of esophageal cancer in China accounted for 53.7% and 55.7% of the world's esophageal cancer cases, respectively [2] .…”

Section: Introductionmentioning

confidence: 99%

Serum hsa-miR-98-5p and RORC may be new biomarkers related to esophageal cancer

Zhou

Wang

et al. 2021

E3S Web Conf.

View full text Add to dashboard Cite

This study aims to use bioinformatics methods to discover new serum miRNA markers for esophageal cancer, and provide a theoretical basis for early diagnosis of esophageal cancer. We used GEO2R to analyze the differential serum miRNAs in esophageal cancer based on GSE112264 from the GEO database. Then target genes of top 10 differential miRNAs were predicted. Obtain RNA-Seq data of esophageal cancer from the TCGA database, and use R software for analysis of differential expression. Overlap the predicted target genes with the differentially down-regulated genes, then perform analysis of GO and KEGG enrichment. Use GEPIA and UALCAN databases to perform verification of expression and prognostic analysis of key genes in the pathway. The results showed there are 2565 differential miRNAs in the serum of esophageal cancer patients. The top 10 up-regulated miRNAs predicted 1676 target genes, then 63 overlapped genes were obtained from target genes and 1642 down-regulated genes. GO enrichment obtained 14 biological processes, and KEGG enrichment obtained the circadian rhythm pathway. Only RORC is related to the poor prognosis of patients with esophageal cancer. Our study concluded serum hsa-miR-98-5p and its target gene RORC may be new biological markers for early diagnosis and treatment of esophageal cancer.

show abstract

“…Previous studies have reported notable heterogeneity in the disease burden of genitourinary cancers at the geographic location, temporal trend, and socio-demographic index (SDI) levels [2][3][4]; however, none of them reported comprehensive data and reflected the changed spectrum. The incidence and mortality on genitourinary cancers have changed significantly in recent years, with the world population growth and aging, the life expectancy increased, and the socioeconomic development [1,5,6]. Hence, longterm, comprehensive, and accurate assessment of the disease burden is the necessary for health policy decision making.…”

Section: Introductionmentioning

confidence: 99%

Global, Regional, and National Burden of Kidney, Bladder, and Prostate Cancers and Their Attributable Risk Factors, 1990-2019

Leng

et al. 2021

Preprint

View full text Add to dashboard Cite

Background: To investigate the burden and attributable risk factors for three genitourinary cancers in 204 countries and territories during 30 years.Methods: We extracted data of kidney, bladder, and prostate cancers from the Global Burden of Disease 2019 database, including incidence, mortality, disability-adjusted life-years (DALYs), and the attributable risk factors from 1990 to 2019. Estimated annual percentage changes (EAPC) were calculated to assess the changes in age-standardized incidence rate, age-standardized mortality rate (ASMR), and age-standardized DALYs rate (ASDR). The associations between cancers burden and socio-demographic index (SDI) were also analyzed.Results: Compared with 1990, the global incident cases of kidney, bladder, and prostate cancers have increased by 154.78%, 123.34%, and 169.11% in 2019. The ASMR and ASDR of bladder cancer (EAPC = -0.68 for ASMR, EAPC = -0.83 for ASDR) and prostate cancer (EAPC = -0.75 for ASMR, EAPC = -0.71 for ASDR) showed a downward trend, but kidney cancer increased (EAPC = 0.35 for ASMR, EAPC = 0.12 for ASDR). Of all cancers, incidence, mortality, and DALYs were higher in the high-level SDI regions and countries. The burden of bladder cancer and prostate cancer was mainly distributed among older men, while the burden of kidney cancer increases among younger men. Smoking related mortality and DALYs decreased, but high body-mass index and high fasting plasma glucose related mortality and DALYs increased among kidney, bladder, and prostate cancers between 1990 and 2019.Conclusions: Kidney, bladder, and prostate cancers remain the major global public health challenge until 2019. We suggest the 204 countries and territories to take positive cancer prevention and intervention strategies, especially the urologists and urological related academic associations.

show abstract

Cancer incidence and mortality in China, 2015

Cited by 305 publications

References 24 publications

Diverging from News Media: An Exploratory Study on the Changing Dynamics between Media and Public Attention on Cancer in China from 2011-2020

Diverging from News Media: An Exploratory Study on the Changing Dynamics between Media and Public Attention on Cancer in China from 2011-2020

Serum hsa-miR-98-5p and RORC may be new biomarkers related to esophageal cancer

Global, Regional, and National Burden of Kidney, Bladder, and Prostate Cancers and Their Attributable Risk Factors, 1990-2019

Contact Info

Product

Resources

About